Skip to main content
Veterinary Medicines

Palmivax atenuowany wirus choroby Derzsy’ego, szczep H, >2,5 log 10 CCID50 i <3,5 log 10 CCID50 Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań

Authorised
  • Derzsy's disease virus, strain Hoekstra, Live

Product identification

Medicine name:
Palmivax atenuowany wirus choroby Derzsy’ego, szczep H, >2,5 log 10 CCID50 i <3,5 log 10 CCID50 Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Active substance:
  • Derzsy's disease virus, strain Hoekstra, Live
Target species:
  • Muscovy duck
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Derzsy's disease virus, strain Hoekstra, Live
    0.40
    cell culture infective dose 50
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Muscovy duck
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01BD01
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • URPL
Authorisation number:
  • 0476
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."